Skip to main content
. Author manuscript; available in PMC: 2013 May 7.
Published in final edited form as: Mol Pharm. 2012 Apr 21;9(5):1441–1448. doi: 10.1021/mp300019c

Figure 4.

Figure 4

Biodistribution studies in 4T1 tumor-bearing mice. (A) Biodistribution of 66Ga-NOTATRC105 at 36 h post-injection, with or without a pre-injected blocking dose of TRC105 (n = 4). (B) Biodistribution of 66Ga-NOTA-TRC105 and 66Ga-NOTA-cetuximab at 36 h post-injection (n = 4). **: P < 0.01.